Side-by-side financials for CVKD and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CVKD | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Net income (latest FY) | -$13.24M | - |
| SEC filings | 237 | 1,004 |
Full pages: Cadrenal Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.